Of the 5145 participants randomly assigned in the Look AHEAD trial ( 2570 to ILI and 2575 to DSE ) , analyses for very-high-risk CKD were done in 2423 ( 94 % ) of patients in the ILI group and 2408 ( 94 % ) of those in the DSE group .